科學家開發出可照亮癌細胞的奈米顆粒，並發現帶狀疱疹疫苗有助於降低失智症風險
Scientists Develop Cancer-Illuminating Nanoparticles and Link Shingles Vaccine to Lower Dementia Risk
Updated at: August 28, 2026 at 03:45 AM
醫學正在兩個關鍵領域取得顯著進展：精準手術與長期大腦健康。
Medical science is making remarkable strides in two vital areas: precision surgery and long-term brain health.
研究人員最近揭示了一種「智慧」奈米粒子，這對治療膠質母細胞瘤(ㄐㄧㄠˊㄓˊㄇㄨˇㄒㄧˊㄅㄠ๑ㄌㄧㄡˊ)等侵襲性腦癌來說是一個關鍵轉折點。
Researchers have recently unveiled "smart" nanoparticles that act as a game-changer for treating aggressive brain cancers like glioblastoma.
這些奈米粒子的功能分為兩個步驟：首先，它們能照亮隱藏的癌細胞，使外科醫生能更精確地觀察並切除腫瘤。
These nanoparticles function in two steps: first, they illuminate hidden cancer cells, allowing surgeons to see and remove tumors more accurately.
同時，預防醫學的進展揭示了帶狀皰疹疫苗（Shingrix）與認知健康之間令人驚訝的聯繫。
Meanwhile, progress in preventive medicine has revealed a surprising link between the Shingles vaccine (Shingrix) and cognitive health.
涉及數千名老年人的大規模研究表明，接種該疫苗可能會將失智症風險降低多達 24%。
Large-scale studies involving thousands of older adults suggest that vaccination may lower the risk of dementia by as much as 24%.
專家認為，該疫苗減少了由休眠的 varicella-zoster 病毒引起的慢性發炎，否則這些發炎可能會隨著時間推移損害大腦健康。
Experts believe the vaccine reduces chronic inflammation caused by the dormant varicella-zoster virus, which may otherwise damage brain health over time.
總體而言，這些突破展示了一種雙重策略：針對活躍疾病治療的高科技精準度，以及針對長期保護的常規免疫接種，這標誌著現代醫學的新前線。
Together, these breakthroughs demonstrate a dual approach: high-tech precision for active disease treatment and routine immunization for long-term protection, marking a new frontier in modern medicine.
